A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Clinical trial NCT07269145 · RECRUITING
Trial details
- NCT number
- NCT07269145
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-22
- Primary completion
- 2026-12-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.